🇺🇸 FDA
Patent

US 9498445

Pharmaceutical compositions for the treatment of Helicobacter pylori

granted A61KA61K31/395A61K31/43

Quick answer

US patent 9498445 (Pharmaceutical compositions for the treatment of Helicobacter pylori) held by RedHill Biopharma Ltd. expires Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
RedHill Biopharma Ltd.
Grant date
Tue Nov 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/395, A61K31/43, A61K31/435, A61K31/438